Stock Taper 
DIADEMA PARTNERS LP
Latest 13F filing data - Q2 2026
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 Novo Nordisk A/S | NVO | 100K | $4.81M |
 Viridian Therapeutics, Inc. | VRDN | 100K | $1.84M |
 Amgen Inc. | AMGN | 102.7K | $214.65K |
 Nurix Therapeutics, Inc. | NRIX | 121.54K | $2.95M |
 Phathom Pharmaceuticals, Inc. | PHAT | 129.95K | $1.41M |
 Xeris Biopharma Holdings, Inc. | XERS | 132.75K | $1.05M |
 Precigen, Inc. | PGEN | 135.29K | $771.17K |
 Revolution Medicines, Inc. | RVMD | 139.22K | $26.07M |
 Zymeworks Inc. | ZYME | 142.13K | $3.72M |
 BioAge Labs Inc. | BIOA | 146.33K | $3.59M |
 Prothena Corporation plc | PRTA | 149.48K | $1.46M |
 Abivax S.A. | ABVX | 163.64K | $21.6M |
 Ocugen, Inc. | OCGN | 200K | $306K |
 Kodiak Sciences Inc. | KOD | 218.12K | $8.5M |
 Arcus Biosciences, Inc. | RCUS | 223.81K | $6.9M |
 Relay Therapeutics, Inc. | RLAY | 230.68K | $4.32M |
 Immunocore Holdings plc | IMCR | 254.86K | $8.09M |
 Edgewise Therapeutics, Inc. | EWTX | 272.21K | $11.06M |
 Corvus Pharmaceuticals, Inc. | CRVS | 294.81K | $4.4M |
 Ardelyx, Inc. | ARDX | 303.02K | $1.55M |